Indian red scorpion venom peptide toxins (BT-toxins)

The venom peptide toxins from the Indian Red Scorpion, Hottentotta tamulus (formerly Buthus tamulus), represent a potent array of neurotoxic peptides that primarily target voltage-gated ion channels in the mammalian nervous system [UniProt, 2024]. These toxins are categorized into several families, most notably the alpha-toxins which bind to site 3 of voltage-gated sodium channels, effectively inhibiting their inactivation and leading to prolonged action potentials [PubMed, 22535314]. Other significant components include potassium channel toxins like Iberiotoxin, which selectively blocks high-conductance calcium-activated potassium (BK) channels [PubChem, 2024]. The synergistic effect of these toxins results in persistent neuronal depolarization and a massive, systemic release of endogenous catecholamines, a phenomenon known as an autonomic storm [The Lancet, 1991]. This clinical state leads to severe cardiovascular complications, including hypertension, myocarditis, and life-threatening pulmonary edema [NCBI, 2023]. While these toxins are the primary agents of envenomation, they serve as critical tools in neurobiology for studying ion channel kinetics and are being investigated as templates for designing highly specific therapeutic peptides [Toxicon, 2015]. Management of envenomation involves the administration of species-specific polyvalent antivenom and the use of alpha-1 adrenoceptor antagonists like prazosin to mitigate the effects of the catecholamine surge [PubMed, 17143017].

Other names

Hottentotta tamulus venom toxinsButhus tamulus venom toxinsMesobuthus tamulus toxinsRed scorpion toxinsIberiotoxinTamulustoxinButantoxin

The toxins bind to specific sites on voltage-gated sodium (Nav) and potassium (K+) channels. Alpha-toxins bind to site 3 of Nav channels, inhibiting inactivation and causing prolonged depolarization. Potassium channel toxins (like Iberiotoxin) block the pore of calcium-activated potassium channels, further increasing excitability and triggering massive neurotransmitter release [PubMed, 22535314; PubChem, 2024].